nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
American Society of Clinical Oncology Annual Meeting 2013
|
Yaqub, Farhat |
|
2013 |
1 |
5 |
p. 360-361 2 p. |
artikel |
2 |
2013 American Thoracic Society International Conference
|
Yaqub, Farhat |
|
2013 |
1 |
5 |
p. 359- 1 p. |
artikel |
3 |
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
|
Lee, Joyce S |
|
2013 |
1 |
5 |
p. 369-376 8 p. |
artikel |
4 |
Anti-acid treatment for idiopathic pulmonary fibrosis
|
Tzouvelekis, Argyris |
|
2013 |
1 |
5 |
p. 348-349 2 p. |
artikel |
5 |
Autopsy in ARDS: insights into natural history
|
Ware, Lorraine B |
|
2013 |
1 |
5 |
p. 352-354 3 p. |
artikel |
6 |
Bone health in cystic fibrosis: use of oral bisphosphonates
|
Henaff, Carole Le |
|
2013 |
1 |
5 |
p. 349-350 2 p. |
artikel |
7 |
Chronic cough as a neuropathic disorder
|
Chung, Kian Fan |
|
2013 |
1 |
5 |
p. 414-422 9 p. |
artikel |
8 |
Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies
|
Thille, Arnaud W |
|
2013 |
1 |
5 |
p. 395-401 7 p. |
artikel |
9 |
Cooking fuels and prevalence of asthma: a global analysis of phase three of the International Study of Asthma and Allergies in Childhood (ISAAC)
|
Wong, Gary WK |
|
2013 |
1 |
5 |
p. 386-394 9 p. |
artikel |
10 |
Corrections
|
|
|
2013 |
1 |
5 |
p. 358- 1 p. |
artikel |
11 |
Fluticasone furoate and vilanterol for COPD
|
Morjaria, Jaymin B |
|
2013 |
1 |
5 |
p. e21- 1 p. |
artikel |
12 |
Fluticasone furoate and vilanterol for COPD – Authors' reply
|
Dransfield, Mark T |
|
2013 |
1 |
5 |
p. e21-e22 nvt p. |
artikel |
13 |
Opening fire on open fires
|
Jarvis, Debbie |
|
2013 |
1 |
5 |
p. 351-352 2 p. |
artikel |
14 |
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges
|
Ruge, Christian A |
|
2013 |
1 |
5 |
p. 402-413 12 p. |
artikel |
15 |
QVA149 versus glycopyrronium for COPD
|
Van Meerhaeghe, Alain |
|
2013 |
1 |
5 |
p. e22-e23 nvt p. |
artikel |
16 |
QVA149 versus glycopyrronium for COPD – Authors' reply
|
Wedzicha, Jadwiga A |
|
2013 |
1 |
5 |
p. e23- 1 p. |
artikel |
17 |
Reducing COPD readmissions—a personal and political priority
|
The Lancet Respiratory Medicine, |
|
2013 |
1 |
5 |
p. 347- 1 p. |
artikel |
18 |
Respiratory health in Russia: time to lift the smokescreen
|
Clark, Fiona |
|
2013 |
1 |
5 |
p. 364-365 2 p. |
artikel |
19 |
Response to “The unknown: respiratory effects of cleaning up an oil spill”
|
Heron, Richard JL |
|
2013 |
1 |
5 |
p. e24-e25 nvt p. |
artikel |
20 |
Shifting attitudes to vaccines and outbreaks of disease
|
Arnold, Carrie |
|
2013 |
1 |
5 |
p. 367- 1 p. |
artikel |
21 |
Smoking cessation and respiratory disease in low-income and middle-income countries
|
Dogar, Omara |
|
2013 |
1 |
5 |
p. e23-e24 nvt p. |
artikel |
22 |
The Power of Two
|
Towey, Francesca |
|
2013 |
1 |
5 |
p. 368- 1 p. |
artikel |
23 |
Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate
|
Bianchi, Maria Luisa |
|
2013 |
1 |
5 |
p. 377-385 9 p. |
artikel |
24 |
Tuberculosis, HIV, and type 2 diabetes mellitus: a neglected priority
|
Oni, Tolu |
|
2013 |
1 |
5 |
p. 356-358 3 p. |
artikel |
25 |
US court rules on donor lung allocation
|
Furlow, Bryant |
|
2013 |
1 |
5 |
p. 363- 1 p. |
artikel |
26 |
Use of bronchoalveolar lavage to assess the respiratory microbiome: signal in the noise
|
Twigg 3rd, Homer L |
|
2013 |
1 |
5 |
p. 354-356 3 p. |
artikel |
27 |
When polio strikes
|
Burki, Talha Khan |
|
2013 |
1 |
5 |
p. 366- 1 p. |
artikel |
28 |
World No Tobacco Day 2013: a regulatory battlefield
|
Burki, Talha |
|
2013 |
1 |
5 |
p. 362- 1 p. |
artikel |